Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas

MLA

Antonio Gutierrez, et al. “Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas.” PLoS ONE, vol. 7, no. 5, May 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d672ced30d3efddac6128c555d388f92&authtype=sso&custid=ns315887.

APA

Antonio Gutierrez, Oliver Vögler, Victor H. Villar, Javier Martin-Broto, Francisca Barceló, Silvia Calabuig-Fariñas, Regina Alemany, Rafael Ramos, & Jordi Martinez-Serra. (2012). Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas. PLoS ONE, 7(5).

Chicago

Antonio Gutierrez, Oliver Vögler, Victor H. Villar, Javier Martin-Broto, Francisca Barceló, Silvia Calabuig-Fariñas, Regina Alemany, Rafael Ramos, and Jordi Martinez-Serra. 2012. “Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas.” PLoS ONE 7 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d672ced30d3efddac6128c555d388f92&authtype=sso&custid=ns315887.